Mark Dalton (businessman)

Mark Dalton is an American chief executive and philanthropist. He serves as the chairman and chief executive officer of the Tudor Investment Corporation.[1][2][3]

Mark Dalton
Born
Mark Foote Dalton
NationalityAmerican
EducationDenison University
Vanderbilt University
Occupationchairman and CEO of the Tudor Investment Corporation
Spouse(s)Susan Dalton
ChildrenErik Dalton
Kurt Dalton
Chris Dalton

Early life

Mark Dalton grew up in Detroit, Michigan, and Dayton, Ohio.[4][5] He graduated from Denison University in 1972 and received a JD from Vanderbilt University School of Law in 1975.[1][2][3][6][7]

Business career

Dalton worked as an attorney for Sullivan & Cromwell in New York City, then served as the chief financial officer for Kidder, Peabody & Co. from 1979 to 1988.[1][2][3][4][5][7] In 1988, he joined the Tudor Investment Corporation, and he currently serves as its co-chairman and chief executive officer.[3][5][7] Dalton is also the chief executive officer of Second Management LLC and the sole General partner at D.F. Partners.[2]

Dalton serves on the boards of directors of Progenics Pharmaceuticals and the Cathay Investment Fund.[5][7] He is a member of Advisory Board at Shah Capital Partners.[2]

Philanthropy

Dalton served as the chairman of the board of trustees of Denison University from 2003 to 2009.[1][7][8] He was the chairman of the board of trustees of Vanderbilt University from 2011 to 2017.[1][6][9]

Dalton serves as chairman of the Sheridan Arts Foundation in Telluride, Colorado.[7][8] He is also a member of the board of directors of the Telluride Foundation and the Buoniconti Fund to Cure Paralysis.[7] Additionally, he is a Board Member of America's Foundation for Chess.[3] Additionally, together with his wife, he has donated more than US$20,000 to the American Hospital of Paris in Neuilly-sur-Seine.[10]

Personal life

He is married to Susan Dalton, a philanthropist.[8] They have three sons: Erik, Kurt and Chris.[8]

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.